ALMS
Price
$4.91
Change
+$0.07 (+1.45%)
Updated
Aug 25, 04:59 PM (EDT)
Capitalization
499.44M
79 days until earnings call
HALO
Price
$72.20
Change
+$0.38 (+0.53%)
Updated
Aug 25, 04:59 PM (EDT)
Capitalization
8.4B
77 days until earnings call
Interact to see
Advertisement

ALMS vs HALO

Header iconALMS vs HALO Comparison
Open Charts ALMS vs HALOBanner chart's image
Alumis
Price$4.91
Change+$0.07 (+1.45%)
Volume$6.99K
Capitalization499.44M
Halozyme Therapeutics
Price$72.20
Change+$0.38 (+0.53%)
Volume$25.44K
Capitalization8.4B
ALMS vs HALO Comparison Chart in %
Loading...
ALMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HALO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALMS vs. HALO commentary
Aug 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALMS is a StrongBuy and HALO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 25, 2025
Stock price -- (ALMS: $4.84 vs. HALO: $71.82)
Brand notoriety: ALMS and HALO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALMS: 90% vs. HALO: 107%
Market capitalization -- ALMS: $499.44M vs. HALO: $8.4B
ALMS [@Biotechnology] is valued at $499.44M. HALO’s [@Biotechnology] market capitalization is $8.4B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.31B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALMS’s FA Score shows that 1 FA rating(s) are green whileHALO’s FA Score has 2 green FA rating(s).

  • ALMS’s FA Score: 1 green, 4 red.
  • HALO’s FA Score: 2 green, 3 red.
According to our system of comparison, HALO is a better buy in the long-term than ALMS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALMS’s TA Score shows that 5 TA indicator(s) are bullish while HALO’s TA Score has 3 bullish TA indicator(s).

  • ALMS’s TA Score: 5 bullish, 4 bearish.
  • HALO’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ALMS is a better buy in the short-term than HALO.

Price Growth

ALMS (@Biotechnology) experienced а +1.89% price change this week, while HALO (@Biotechnology) price change was +6.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.14%. For the same industry, the average monthly price growth was +18.77%, and the average quarterly price growth was +29.32%.

Reported Earning Dates

ALMS is expected to report earnings on Nov 12, 2025.

HALO is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+2.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HALO($8.4B) has a higher market cap than ALMS($499M). HALO has higher P/E ratio than ALMS: HALO (16.43) vs ALMS (0.15). HALO YTD gains are higher at: 50.220 vs. ALMS (-38.422). HALO has higher annual earnings (EBITDA): 792M vs. ALMS (-435.74M). HALO has more cash in the bank: 548M vs. ALMS (486M). ALMS has less debt than HALO: ALMS (38.8M) vs HALO (1.51B). HALO has higher revenues than ALMS: HALO (1.18B) vs ALMS (20.1M).
ALMSHALOALMS / HALO
Capitalization499M8.4B6%
EBITDA-435.74M792M-55%
Gain YTD-38.42250.220-77%
P/E Ratio0.1516.431%
Revenue20.1M1.18B2%
Total Cash486M548M89%
Total Debt38.8M1.51B3%
FUNDAMENTALS RATINGS
HALO: Fundamental Ratings
HALO
OUTLOOK RATING
1..100
48
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
30
SMR RATING
1..100
11
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
87
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALMSHALO
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
59%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
65%
Momentum
ODDS (%)
Bullish Trend 4 days ago
74%
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
63%
Bullish Trend 4 days ago
75%
Advances
ODDS (%)
Bullish Trend 4 days ago
67%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 25 days ago
68%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
58%
Aroon
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
ALMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HALO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SSMGX69.901.72
+2.52%
Sit Small Cap Growth
BKTSX29.500.50
+1.72%
iShares Total US Stock Market Idx K
ACGGX20.790.32
+1.56%
American Century Global Gold A
RNPHX71.221.06
+1.51%
American Funds New Perspective R5E
FEQJX14.340.19
+1.34%
Fidelity Advisor Hedged Equity Fund I

ALMS and

Correlation & Price change

A.I.dvisor tells us that ALMS and ADAP have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALMS and ADAP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALMS
1D Price
Change %
ALMS100%
+5.22%
ADAP - ALMS
29%
Poorly correlated
-2.74%
ATXS - ALMS
26%
Poorly correlated
+6.93%
ELEV - ALMS
24%
Poorly correlated
N/A
HALO - ALMS
24%
Poorly correlated
+0.29%
OABI - ALMS
23%
Poorly correlated
+2.78%
More